Advanced Therapy Medicinal Products (ATMPs) are revolutionising healthcare. This programme provides comprehensive insights into the research, regulation, and commercialization of ATMPs, guided by leading experts from Europe and the USA.
You will gain knowledge from established professionals on the development, production, and regulatory challenges of gene and cell therapy products. Delivered through innovative recorded talks and Q&A sessions, the course offers a self-paced learning experience, ideal for those looking to stay ahead in the fast-evolving ATMP landscape.
Applications to this programme are currently closed. Be the first to know about upcoming programmes and opportunities that may be a good fit for you by joining our mailing list.
• Introductory e-course
• Genome editing for gene therapy development
• ATMP Regulatory framework
• Preclinical models
• Introduction to GMP (Manufacturing)
• Release criteria: Tissue engineering products
• Clinical trial design
• Biostatistics in ATMP development
• Patient involvement/engagement in the ATMP field
• Late-stage development & market access
• Commercialisation
The course is open to all postgraduate students, healthcare or industry professionals:
• Have undertaken undergraduate and/or post graduate studies
• Have a B1 English level
• Interest in a deeper dive in the ATMPs and associated products and therapies
Understand the core principles of Advanced Therapy Medicinal Products and how they can be implemented.
Attending and completing the introductory e-course is mandatory for all learners that want to apply for the rest of the courses across the theme.
Join our mailing list to, be the first to know when this programme is open for applications and stay up to date with upcoming programmes and opportunities that may be a good fit for you.